Dfdiscover software license agreement

Closed Solicitation Posted

Solicitation number
NOI-NIAID-25-2254452
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Rockville, Maryland 20852, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking to renew a software license agreement for DFdiscover, a Clinical Data Management System used to support international clinical trials and research protocols. The agency intends to negotiate on a sole-source basis with DF/Net Research, Inc. for a software license that supports clinical data collection and management across multiple international research sites. The system must be capable of functioning in remote locations with limited internet access, supporting data submission through various methods including fax and electronic data capture. Capabilities statements must demonstrate the ability to provide priority response equivalent to a direct service agreement with the manufacturer. All responsible sources may submit a capabilities statement through the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 pm Eastern Standard Time on April 7, 2025.

The contract will cover a one-year period from May 1, 2025, through April 30, 2026, and currently supports approximately 900 active users across clinical trials in countries including Mali, Uganda, Cameroon, Thailand, Cambodia, India, South Africa, and the United States. The license includes three different agreement types and a Large Study Numbers extension that increases the study limit from 250 to 999 per server. The software is FDA-compliant (21CFR part 11) and considered an industry standard for clinical data management. The place of performance is located in Rockville, MD, and the procurement falls under the NAICS category for Electronic and Precision Equipment Repair and Maintenance. There is no specific set-aside designation for this opportunity, and the procurement is being conducted under the statutory authority of 41 U.S.C. 1901(a)(1), which allows for sole-source procurement when only one responsible source can satisfy agency requirements.

Notice text

This is a Notice of Intent, not a request for proposal.  The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate an other than full and open competition basis with DF/Net Research, Inc. for a DFdiscover Software License Agreement.

The Office of Cyber Infrastructure and Computational Biology (OCICB) within the National Institutes of Allergy and Infectious Diseases (NIAID) provides leadership and direction on effective strategies, policies, and standards for technology services, support for biomedical research programs, information technology resources, and customer support.  This includes ensuring information technology infrastructure, tools, and applications fully and comprehensively support the NIAID mission. The Clinical Informatics Branch within the OCICB provides specialized support to facilitate the integration of IT and clinical expertise to support NIAID’s research mission. The branch specializes in leveraging expertise to manage the implementation and configuration of industry standard research management tools.  In addition, the International Biomedical Research Support Program within the branch focuses on providing information technology and communication systems support for biomedical research at various national and international medical research facilities. DFdiscover is a Clinical Data Management System that is used by OCICB and NIH lab partners to support clinical trials and studies globally for International collaborative research protocols. 

The Office of Cyber Infrastructure and Computational Biology (OCICB), International Biomedical Research Support Program (IBRSP) within the Clinical Informatics Branch (CIB) is requesting to renew and decrease the DFdiscover software license agreements starting May 1, 2025. DFdiscover is an agile clinical data management solution that streamlines data collection from every source and brings flexibility, quality, and speed to the daily work of collecting, verifying, and analyzing clinical data. This renewal includes 3 different license agreements as well as a Large Study Numbers extension - Applicable for all servers with DF2018 or newer which also extends the limit on number of studies per server from 250 to 999. DFdiscover (formerly Datafax) is a Clinical Data Management System that is currently used by OCICB and NIH lab partners to support more than 130 clinical trials and studies globally for International collaborative research protocols in the following countries, Mali, Uganda, Cameroon, Thailand, Cambodia, India, South Africa and in the United States. Currently, the DFdiscover server supports a user group with about 900 active users who have been trained and work within the system. DF/Net is the vendor and sole seller of the product, which is compliant with the FDA regulations, 21CFR part 11, and is used as an industry standard worldwide by pharmaceutical companies. Various NIAID international collaborative research protocols are conducted in remote locations and some of these clinical sites do not have reliable internet access and therefore need a system that can be used with older technology such as fax machines for submitting paper Clinical Report Forms (CRFs) into a Clinical Data Management System database but also has the flexibility to use Electronic Data Capture and mobile data capture. The Period of Performance date for the purchase is May 1, 2025, through April 30, 2026.

Capabilities statements must address the capability of providing a priority response equal to a direct contract/service agreement with the manufacturer.

The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide comparable services may submit a capabilities statement that will be considered. The documents must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov, (subject line to reference NOI-NIAID-25-2254452 by 12:00 pm eastern standard time April 7, 2025. All vendors must register in the eSASS system to submit a capabilities statement. Instructions on how to register / submit quotes are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit a capabilities statement that will be considered by this Agency. 

Similar open opportunities

Opportunity Agency Set-aside Responses due
Octet RH96 preventive service plan for sartorius octet instruments Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases NAICS 541715 National Institute of Allergy and Infectious Diseases No set-aside
Notice of Intent to Sole Source – INFOR (US), LLC - Cloverleaf Bethesda, Maryland 20892, United States · NAICS 541519 Office of Logisitics and Acquisition Operations No set-aside
ASIT. TO 1 year software support from ArgonSoft (Notice of Intent to sole source) Bethesda, Maryland 20814, United States · NAICS 513210 NIH Clinical Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity